News & events

RSS feeds RSS feeds

Our latest announcements

30/07/2010 — Research Update - Summer 2010
29/07/2010 — Apply for a Population Research Postdoctoral Fellowship
29/07/2010 — Apply for Population Research Postdoctoral Fellowship
29/07/2010 — Applications invited for Population Research Postdoctoral Fellowships
29/07/2010 — Population Research Postdoctoral Fellowships available for application
09/07/2010 — Revision of 2010 Terms and Conditions for Research Grants and Awards
24/06/2010 — Launch of new Funding and Research website
23/06/2010 — Funding for new investigators
22/09/2009 — Cancer Research UK ploughs millions into new Drug Discovery Programmes
06/04/2009 — Final stages of Research Services decentralisation
See all announcements ›

Latest cancer news RSS Feed


How to subscribe

Advanced search

  1. Press Release: Trial to test experimental drug for advanced pancreatic cancer

    2 Sep 2010

    Cancer Research UK's Drug Development Office has launched a clinical trial to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat.

  2. Press Release: Half of Brits got sunburnt this year and many would do it again

    1 Sep 2010

    A NEW survey released today (Wednesday 1 September) reveals almost half of Brits (46 per cent) got sunburnt this year. Of those who got burnt, a third (32 per cent) admitted their motivation was to get a tan. And half of those who burnt whilst trying to get a tan would risk burning again next year.

  3. Press Release: Oesophageal cancer rates in men up 50 per cent in a generation

    28 Aug 2010

    Oesophageal cancer rates in men have risen by 50 per cent over the last 25 years, according to new figures published by Cancer Research UK today.

  4. News story: Trial drug 'effective' against cancers with faulty BRAF gene

    26 Aug 2010

    An experimental drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.

  5. News story: NICE recommends bortezomib and thalidomide for multiple myeloma

    26 Aug 2010

    The National Institute for Health and Clinical Excellence (NICE) has released draft guidance which recommends the drugs bortezomib and thalidomide as first-line therapies for some patients with multiple myeloma, a type of cancer that affects cells in the bone marrow.